Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055.
Antoine BachelardValentina IserniaCharlotte CharpentierAida BenalycherifMarion MoraCécile DonadilleClaudine DuvivierKarine LacombeMayssam El MouhebbBruno SpireRoland LandmanDiane DescampsGilles PeytavinLambert AssoumouJade Ghosnnull nullPublished in: The Journal of antimicrobial chemotherapy (2023)
These results suggest that BIC/FTC/TAF is safe, effective and well accepted for same-day initiation.